MBL International Corporation
MBL International Corporation provides products for both life science research and clinical diagnostics. MBL develops, manufactures, and markets a broad portfolio of monoclonal and polyclonal antibodies, MHC tetramers, fluorescent and recombinant proteins and ELISA kits for research related to allergy, apoptosis, autophagy, cancer, epigenetics, immunology, and neuroscience. We have recently added new products including flow cytometry, exosome research products, and 3D cell culture (NCP) products to our portfolio.